Literature DB >> 26068429

Prescription patterns of Chinese herbal products for patients with sleep disorder and major depressive disorder in Taiwan.

Yi-Lin Chen1, Chien-Ying Lee2, Kuang-Hua Huang3, Yu-Hsiang Kuan2, Ming Chen4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Chinese herbal products (CHPs) are commonly prescribed for sleep disorder and major depressive disorder (MDD). The aim of this study was to investigate the prescription patterns of CHPs and Western medicine for patients with these disorders in Taiwan, and analyze the frequency of using single herbs (SHs) and herbal formulas (HFs).
MATERIALS AND METHODS: In this retrospective population-based study secondary data analysis was performed using data from Taiwan's Longitudinal Health Insurance Database (LHID) between January 2007 and December 2011. In total, 1000,000 beneficiaries from the LHID were randomly selected from the 2010 registry for beneficiaries of the National Health Insurance Research Database. Patients with sleep disorder and MDD according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes 307.40 and 311, respectively.
RESULTS: Among a total of 11,030 patients with sleep disorder, 9619 used Western medicine, 1334 used CHPs, and 77 used both, Among a total of 11,571 patients with MDD, 11,389 used Western medicine, 131 used CHPs, and 51 used both. Regardless of disorder type, women were predominant The majority of the patients were aged 22-44 years, had a monthly income of NT$17,281-NT$22,800, and lived in an area with Level 1 and Level 2 urbanization. Of the patients with sleep disorder, 1411 had used CHPs and visited a clinic 5298 times on average. Of the patients with MDD, 182 had used CHPs and visited a clinic 755 times on average. The three most commonly used SHs and HFs were Ziziphi Spinosae Semen, Polygoni Multiflori Caulis, and Polygalae Radix, and Jia-Wei-Xiao-Yao-San, Suan-Zao-Ren-Tang, and Chai-Hu-Chia-Lung-Ku-Mu-Li-Tang, respectively.
CONCLUSION: Chinese herbal products including SHs and HFs are prescribed for patients with sleep disorder and MDD. However, the efficacy and safety of CHPs for sleep disorder and MDD need to be further evaluated.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Benzodiazepine (PubChem CID: 134664); Chinese herbal product (CHP); Clomipramine (PubChem CID: 2801); Doxepin (PubChem CID: 667477); Escitalopram (PubChem CID: 146571); Fluoxetine (PubChem CID: 62857); Imipramine (PubChem CID: 3696); Jia-Wei-Xiao-Yao-San; Major depressive disorder (MDD); Maprotiline (PubChem CID: 4011); National Health Insurance Research Database (NHIRD); Paroxetine (PubChem CID: 43815); Sertraline (PubChem CID: 68617); Sleep disorder; Ziziphi spinosae semen; Zolpidem (PubChem CID: 5732)

Mesh:

Substances:

Year:  2015        PMID: 26068429     DOI: 10.1016/j.jep.2015.05.045

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  18 in total

1.  Multistage analysis method for detection of effective herb prescription from clinical data.

Authors:  Kuo Yang; Runshun Zhang; Liyun He; Yubing Li; Wenwen Liu; Changhe Yu; Yanhong Zhang; Xinlong Li; Yan Liu; Weiming Xu; Xuezhong Zhou; Baoyan Liu
Journal:  Front Med       Date:  2017-06-14       Impact factor: 4.592

2.  The Antidepressant Effect of Angelica sinensis Extracts on Chronic Unpredictable Mild Stress-Induced Depression Is Mediated via the Upregulation of the BDNF Signaling Pathway in Rats.

Authors:  Jun Shen; Junjian Zhang; Min Deng; Yue Liu; Yuan Hu; Lei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-08-25       Impact factor: 2.629

3.  Improved medical expenditure and survival with integration of traditional Chinese medicine treatment in patients with heart failure: A nationwide population-based cohort study.

Authors:  Ming-Yen Tsai; Wen-Long Hu; Jen-Huai Chiang; Yu-Chuen Huang; Shih-Yu Chen; Yu-Chiang Hung; Yung-Hsiang Chen
Journal:  Oncotarget       Date:  2017-08-08

4.  Screening of sleep assisting drug candidates with a Drosophila model.

Authors:  Yan-Ying Wang; Wei-Wei Ma; I-Feng Peng
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

5.  Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan.

Authors:  Fuu-Jen Tsai; Pei-Yuu Yang; Chao-Jung Chen; Ju-Pi Li; Te-Mao Li; Jian-Shiun Chiou; Chi-Fung Cheng; Po-Heng Chuang; Ting-Hsu Lin; Chiu-Chu Liao; Shao-Mei Huang; Bo Ban; Wen-Miin Liang; Ying-Ju Lin
Journal:  BMC Complement Med Ther       Date:  2020-07-14

6.  Decreased risk of dementia in migraine patients with traditional Chinese medicine use: a population-based cohort study.

Authors:  Chun-Ting Liu; Bei-Yu Wu; Yu-Chiang Hung; Lin-Yi Wang; Yan-Yuh Lee; Tsu-Kung Lin; Pao-Yen Lin; Wu-Fu Chen; Jen-Huai Chiang; Sheng-Feng Hsu; Wen-Long Hu
Journal:  Oncotarget       Date:  2017-07-08

7.  Effects of Chinese herbal medicines on the occurrence of diabetic retinopathy in type 2 diabetes patients and protection of ARPE-19 retina cells by inhibiting oxidative stress.

Authors:  Fuu-Jen Tsai; Te-Mao Li; Cheng-Hang Ko; Wen-Miin Liang; Ying-Ju Lin; Chi-Fung Cheng; Tsung-Jung Ho; Xiang Liu; Hsinyi Tsang; Ting-Hsu Lin; Chiu-Chu Liao; Ju-Pi Li; Shao-Mei Huang; Jung-Chun Lin; Chih-Chien Lin
Journal:  Oncotarget       Date:  2017-06-29

8.  A Computational Systems Pharmacology Approach to Investigate Molecular Mechanisms of Herbal Formula Tian-Ma-Gou-Teng-Yin for Treatment of Alzheimer's Disease.

Authors:  Tianduanyi Wang; Zengrui Wu; Lixia Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

9.  Bioinspired Honokiol Analogs and Their Evaluation for Activity on the Norepinephrine Transporter.

Authors:  Kristen Stout; Marketa Bernaskova; Gary W Miller; Antje Hufner; Wolfgang Schuehly
Journal:  Molecules       Date:  2018-10-04       Impact factor: 4.411

10.  Albizia julibrissin Ameliorates Memory Loss Induced by Insomnia in Drosophila.

Authors:  Jui-Shu Chang; Hsin-Ping Liu; Jack Cheng; Chao-Jung Chen; Su-Lun Hwang; Chi-Chuan Tseng; Lee-Fen Hsu; Wei-Yong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.